COL9A3 Antikörper (AA 501-528)

Produktnummer ABIN1881221

Produktdetails anti-COL9A3 Antikörper

Target: COL9A3 (Collagen, Type IX, alpha 3 (COL9A3))

Bindungsspezifität: AA 501-528

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser COL9A3 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Aufreinigung: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogen: This COL9A3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 501-528 amino acids from the Central region of human COL9A3.

Klon: RB42519

Isotyp: Ig Fraction

Anwendungsinformationen

Applikationshinweise: WB: 1:1000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Haltbarkeit: 6 months

Referenzen für anti-COL9A3 Antikörper (ABIN1881221)

Videman, Saarela, Kaprio, Näkki, Levälahti, Gill, Peltonen, Battié: "Associations of 25 structural, degradative, and inflammatory candidate genes with lumbar disc desiccation, bulging, and height narrowing." in: Arthritis and rheumatism, Vol. 60, Issue 2, pp. 470-81, (2009) (PubMed).

Karppinen, Daavittila, Solovieva, Kuisma, Taimela, Natri, Haapea, Korpelainen, Niinimäki, Tervonen, Ala-Kokko, Männikkö: "Genetic factors are associated with modic changes in endplates of lumbar vertebral bodies." in: Spine, Vol. 33, Issue 11, pp. 1236-41, (2008) (PubMed).

Decramer, Bascands, Schanstra: "Non-invasive markers of ureteropelvic junction obstruction." in: World journal of urology, Vol. 25, Issue 5, pp. 457-65, (2007) (PubMed).

Virtanen, Karppinen, Taimela, Ott, Barral, Kaikkonen, Heikkilä, Mutanen, Noponen, Männikkö, Tervonen, Natri, Ala-Kokko: "Occupational and genetic risk factors associated with intervertebral disc disease." in: Spine, Vol. 32, Issue 10, pp. 1129-34, (2007) (PubMed).

Details zu COL9A3

Target: COL9A3 (Collagen, Type IX, alpha 3 (COL9A3))

Andere Bezeichnung: COL9A3 (COL9A3 Produkte)

Synonyme: DJ885L7.4.1 antikoerper, EDM3 antikoerper, IDD antikoerper, MED antikoerper, AV006866 antikoerper, col9a3 antikoerper, MGC80136 antikoerper, cb367 antikoerper, sb:cb367 antikoerper, wu:fa04f01 antikoerper, si:ch73-162j3.1 antikoerper, COL9A3 antikoerper, LOC100221007 antikoerper, collagen type IX alpha 3 chain antikoerper, collagen, type IX, alpha 3 antikoerper, collagen, type IX, alpha 3 L homeolog antikoerper, COL9A3 antikoerper, Col9a3 antikoerper, col9a3.L antikoerper, col9a3 antikoerper

Hintergrund: This gene encodes one of the three alpha chains of type IX collagen, the major collagen component of hyaline cartilage. Type IX collagen, a heterotrimeric molecule, is usually found in tissues containing type II collagen, a fibrillar collagen. Mutations in this gene are associated with multiple epiphyseal dysplasia type 3.

Molekulargewicht: 63616

NCBI Accession: NP_001844

UniProt: Q14050